Corebridge Financial Inc. Sells 436 Shares of Astrana Health, Inc. $ASTH

Corebridge Financial Inc. decreased its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 1.9% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,454 shares of the company’s stock after selling 436 shares during the period. Corebridge Financial Inc.’s holdings in Astrana Health were worth $696,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Two Sigma Investments LP bought a new position in Astrana Health during the fourth quarter valued at $466,000. Hussman Strategic Advisors Inc. increased its position in Astrana Health by 33.3% during the first quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company’s stock valued at $2,605,000 after acquiring an additional 21,000 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in Astrana Health by 6.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company’s stock valued at $15,490,000 after acquiring an additional 28,200 shares during the last quarter. Northern Trust Corp increased its position in Astrana Health by 10.1% during the fourth quarter. Northern Trust Corp now owns 467,179 shares of the company’s stock valued at $14,730,000 after acquiring an additional 43,032 shares during the last quarter. Finally, Bank of America Corp DE increased its position in Astrana Health by 44.2% during the fourth quarter. Bank of America Corp DE now owns 97,721 shares of the company’s stock valued at $3,081,000 after acquiring an additional 29,971 shares during the last quarter. Institutional investors own 52.77% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Zacks Research cut shares of Astrana Health from a “strong-buy” rating to a “strong sell” rating in a research report on Monday, September 1st. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $53.29.

Astrana Health Trading Down 3.6%

NASDAQ ASTH opened at $29.70 on Friday. The company’s 50-day moving average price is $26.48 and its 200-day moving average price is $28.13. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52. The stock has a market cap of $1.66 billion, a PE ratio of 58.24, a PEG ratio of 0.74 and a beta of 0.85. Astrana Health, Inc. has a 12 month low of $21.20 and a 12 month high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.17). The company had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The company’s revenue for the quarter was up 34.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.40 earnings per share. Astrana Health has set its Q3 2025 guidance at EPS. Equities research analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.